21 related articles for article (PubMed ID: 1313373)
1. Methylene blue for distributive shock: a potential new use of an old antidote.
Jang DH; Nelson LS; Hoffman RS
J Med Toxicol; 2013 Sep; 9(3):242-9. PubMed ID: 23580172
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP.
Boese M; Busse R; Mülsch A; Schini-Kerth V
Br J Pharmacol; 1996 Oct; 119(4):707-15. PubMed ID: 8904645
[TBL] [Abstract][Full Text] [Related]
3. Plasma cyclic guanosine 3'-5' monophosphate concentrations and low vascular resistance in human septic shock.
Schneider F; Lutun P; Couchot A; Bilbault P; Tempé JD
Intensive Care Med; 1993; 19(2):99-104. PubMed ID: 8387555
[TBL] [Abstract][Full Text] [Related]
4. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
[TBL] [Abstract][Full Text] [Related]
5. Role of endotoxin in L-arginine-induced relaxation of rat thoracic aorta mediated by muscle-derived nitric oxide.
Moritoki H; Takeuchi S; Kondoh W; Hisayama T; Hashizume M; Noda K
Arch Int Pharmacodyn Ther; 1994; 327(2):152-65. PubMed ID: 7526814
[TBL] [Abstract][Full Text] [Related]
6. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
7. Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery.
Bucher B; Ouedraogo S; Tschöpl M; Paya D; Stoclet JC
Br J Pharmacol; 1992 Dec; 107(4):976-82. PubMed ID: 1334757
[TBL] [Abstract][Full Text] [Related]
8. L-arginine induces relaxation of small mesenteric arteries from endotoxin-treated rats.
Schneider F; Schott C; Stoclet JC; Julou-Schaeffer G
Eur J Pharmacol; 1992 Feb; 211(2):269-72. PubMed ID: 1612111
[TBL] [Abstract][Full Text] [Related]
9. The L-arginine-NO pathway and cyclic GMP in the vessel wall.
Stoclet JC
Z Kardiol; 1991; 80 Suppl 7():87-90. PubMed ID: 1665267
[TBL] [Abstract][Full Text] [Related]
10. Clinical relationships of cyclic GMP.
Cusson JR; Tremblay J; Larochelle P; Schiffrin EL; Gutkowska J; Hamet P
Adv Pharmacol; 1994; 26():305-19. PubMed ID: 8038107
[No Abstract] [Full Text] [Related]
11. Effect of endotoxin on circulating cyclic GMP in the rat.
Schuller F; Fleming I; Stoclet JC; Gray GA
Eur J Pharmacol; 1992 Feb; 212(1):93-6. PubMed ID: 1313373
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
